MXPA05013270A - Forma de administracion transmucosal con irritacion mucosal reducida. reducida. - Google Patents

Forma de administracion transmucosal con irritacion mucosal reducida. reducida.

Info

Publication number
MXPA05013270A
MXPA05013270A MXPA05013270A MXPA05013270A MXPA05013270A MX PA05013270 A MXPA05013270 A MX PA05013270A MX PA05013270 A MXPA05013270 A MX PA05013270A MX PA05013270 A MXPA05013270 A MX PA05013270A MX PA05013270 A MXPA05013270 A MX PA05013270A
Authority
MX
Mexico
Prior art keywords
administration
forms
mucosal irritation
transmucosal
value
Prior art date
Application number
MXPA05013270A
Other languages
English (en)
Inventor
Christian Von Falkenhausen
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of MXPA05013270A publication Critical patent/MXPA05013270A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Abstract

La presente invencion se refiere a formas de administracion en forma de pelicula para la administracion transmucosal de sustancias activas en el cuerpo humano o animal. Las formas de administracion se caracterizan por una adaptacion o aproximacion del valor de pH de la masa basica usada para producir la forma de administracion y comprende un solvente o una mezcla de solventes, al menos un polimero que forma una matriz y al menos una sustancia activa, al valor del pH fisiologico de la membrana mucosa para la aplicacion. La invencion tambien se refiere a un metodo para producir tales preparaciones y al uso de las mismas como formas de administracion, especialmente para sustancias activas farmaceuticas, de tal forma que la irritacion mucosal se reduce o aun se previene por la aplicacion de las formas de administracion resultantes.
MXPA05013270A 2003-06-27 2004-06-19 Forma de administracion transmucosal con irritacion mucosal reducida. reducida. MXPA05013270A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10328942A DE10328942A1 (de) 2003-06-27 2003-06-27 Transmukosale Darreichungsformen mit verminderter Schleimhautirritation
PCT/EP2004/006659 WO2005000263A1 (de) 2003-06-27 2004-06-19 Transmukosale darreichungsform mit vreminderter schleimhautirritation

Publications (1)

Publication Number Publication Date
MXPA05013270A true MXPA05013270A (es) 2006-03-17

Family

ID=33546679

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05013270A MXPA05013270A (es) 2003-06-27 2004-06-19 Forma de administracion transmucosal con irritacion mucosal reducida. reducida.

Country Status (12)

Country Link
US (1) US20060182786A1 (es)
EP (1) EP1638521A1 (es)
JP (1) JP2007506670A (es)
KR (1) KR20060037279A (es)
CN (1) CN1812765B (es)
AU (1) AU2004251018B2 (es)
BR (1) BRPI0411832A (es)
CA (1) CA2524937A1 (es)
DE (1) DE10328942A1 (es)
MX (1) MXPA05013270A (es)
WO (1) WO2005000263A1 (es)
ZA (1) ZA200508801B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006027792A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antidepressiva-Kombinations-Wafer
DE102006027793A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Opioid-Kombinations-Wafer
DE102006027795A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Raucherentwöhnungs-Kombinationswafer
JP5518720B2 (ja) * 2007-10-11 2014-06-11 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 無煙タバコ製品
DE102008011800A1 (de) 2008-02-29 2009-10-15 Acino Ag Oral zerfallender Film zur therapeutischen Anwendung von Antiparasitika bei Tieren
US8642029B2 (en) 2008-03-31 2014-02-04 Osel, Inc. Transiently buffered Lactobacillus preparations and use thereof
CN102056578A (zh) * 2008-06-23 2011-05-11 生物递送科学国际公司 多向粘膜给药装置及使用方法
CN102427782A (zh) * 2009-05-21 2012-04-25 比奥内克斯制药有限公司 双层和单层剂型
CN102488672A (zh) * 2011-12-16 2012-06-13 焦作市银达生物制品有限公司 一种水溶胶透皮给药系统
US10806703B2 (en) * 2012-01-20 2020-10-20 Lts Lohmann Therapie-System Ag Transmucosal administration system for a pharmaceutical drug
CN103439241B (zh) * 2013-08-23 2016-03-16 东南大学 单细胞多参数表征的微流控芯片检测系统
GB2575625A (en) 2018-06-22 2020-01-22 Church & Dwight Co Inc Oral care compositions comprising benzocaine and mucoadhesive thin films formed therefrom
DE102019135432A1 (de) * 2019-12-20 2021-06-24 Lts Lohmann Therapie-Systeme Ag Lösliche Rückschicht für OTF
EP4149419A1 (en) 2020-05-11 2023-03-22 Symrise AG A solid mucoadhesive composition
DE102021105268A1 (de) * 2021-03-04 2022-09-08 Lts Lohmann Therapie-Systeme Ag. Oraler Dünnfilm

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CH653550A5 (de) * 1981-10-20 1986-01-15 Sandoz Ag Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich.
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
JPS6393717A (ja) * 1986-10-09 1988-04-25 Sekisui Chem Co Ltd 口腔粘膜用粘着剤もしくは接着剤
DE3827561C1 (es) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
EP0386960A3 (en) * 1989-03-07 1991-10-23 American Cyanamid Company Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
AU667161B2 (en) * 1993-04-28 1996-03-07 Daiichi Pharmaceutical Co., Ltd. Butyrophenone transdermal compositions
FR2742989B1 (fr) * 1995-12-29 1998-01-23 Adir Composition pharmaceutique bioadhesive pour la liberation controlee de principes actifs
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US6136297A (en) * 1997-06-06 2000-10-24 The Procter & Gamble Company Delivery system for an oral care substance using a strip of material having low flexural stiffness
WO1999053897A2 (en) * 1998-04-21 1999-10-28 Infectio Recherche Inc. Topical formulation comprising poloxamers and further microbicides, and an applicator
ATE392863T1 (de) * 2001-08-17 2008-05-15 Smithkline Beecham Plc Streifen zur abgabe eines mundpflegewirkstoffes
JP5089840B2 (ja) * 2001-09-25 2012-12-05 救急薬品工業株式会社 ニコチン含有フィルム製剤
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US20030099691A1 (en) * 2001-11-16 2003-05-29 Susan Lydzinski Films containing starch

Also Published As

Publication number Publication date
ZA200508801B (en) 2006-07-26
US20060182786A1 (en) 2006-08-17
EP1638521A1 (de) 2006-03-29
KR20060037279A (ko) 2006-05-03
WO2005000263A1 (de) 2005-01-06
JP2007506670A (ja) 2007-03-22
BRPI0411832A (pt) 2006-08-08
CN1812765A (zh) 2006-08-02
AU2004251018A1 (en) 2005-01-06
CA2524937A1 (en) 2005-01-06
DE10328942A1 (de) 2005-01-27
CN1812765B (zh) 2010-05-12
AU2004251018B2 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
MXPA05013270A (es) Forma de administracion transmucosal con irritacion mucosal reducida. reducida.
MXPA04007980A (es) Preparado farmaceutico de sabor enmascarado en forma de pelicula o de oblea.
AP1760A (en) Platinum derivative pharmaceutical formulations.
HUP0102039A2 (hu) Albuminnal stabilizált paclitaxel alkalmazása tömör tumorok kezelésére szolgáló gyógyszerkészítmények előállítására, és a kapott gyógyszerkészítmények
MXPA03010402A (es) Derivados de 4-amino-5-fenil-7-ciclobutil-pirrolo (2,3-d) pirimidina.
FR11C0017I1 (es)
DE60121301D1 (de) Flibanserin zur Behandlung extrapyramidaler Bewegungsstörungen
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
HUP0105173A2 (hu) Adagolási módszer és készítmény sürgősségi fogamzásgátlásra
HUP0303454A2 (hu) 4-Ciano-trifluor-3-(4-fluor-fenil-szulfonil)-2-hidroxi-2-metil-propiono-m-toluididet és pvp-t tartalmazó szilárd gyógyászati készítmény
WO2002045686A3 (en) Pharmaceutical paste comprising an acid-labile active ingredient
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
DE60100994D1 (de) Transdermales therapeutisches System für die Erzielung hoher Plasmaspiegel von Rotigotin in der Therapie von Morbus Parkinson
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
DK1343472T3 (da) Thixotropisk næsespray
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
CA2505500A1 (en) Method of stimulating hair growth using benzopyrans
CA2429793A1 (en) Interferon therapeutic effect enhancer
WO2001080891A8 (fr) Substances medicamenteuses destinees a la pneumonie interstitielle, procede de construction d'un modele animal de cette maladie et procede de criblage dans lequel on utilise ce dernier
WO2003043632A3 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
WO2004030684A3 (en) Kavalactone product
WO2001045727A3 (en) Stabilized veterinary compositions comprising more than one antiviral agent
WO2002072016A3 (en) Method of preventing adhesions with ifn-¿y?
UA41154A (uk) Лікувальний засіб "гермогран-м" на основі олії з зародків пшениці

Legal Events

Date Code Title Description
FG Grant or registration